The date, at a fancy London restaurant, had been enjoyable. However, it never even crossed Sharon Gavin's mind to invite her ...

Medications like Ozempic only address part of food addiction. Discover the essential components of effective recovery beyond ...

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...

Unions blame ‘greed’ by healthcare providers, state officials say pricey weight-loss meds and increasing demand for care are ...

A revolution in weight loss treatment may soon be on the way — and it doesn’t involve a needle. Eli Lilly, the pharmaceutical ...

Here are five reasons to feel good about eating dark chocolate (anything 70 per cent cocoa or higher) regularly. Cocoa – the ...

Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...

There’s a certain agreement one must enter into when deciding to have some fun. If that fun entails a night on the town, a ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

NVO stock declines 3% as the company announces that Lars Fruergaard Jorgensen will be stepping down as the CEO.

Dozens of Ozempic and Wegovy users have reported suffering from eye disorders they claim are associated with the drugs, including eight who have complained of blindness.

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.